Business Context and Reporting Period
Company: SELLAS Life Sciences Group, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 25, 2018
Event: Entry into a Material Definitive Agreement involving the exchange of warrants for a convertible promissory note.
Key Financial Metrics and Transaction Details
This filing reports a specific capital transaction rather than periodic financial performance metrics (revenue, profit, cash flow). The key financial terms of the transaction are:
- Instrument Issued: Convertible Promissory Note (Intracoastal Note).
- Principal Amount: $78,000.
- Interest Rate: 5% per annum (increases to 18% per annum upon an event of default).
- Maturity Date: November 25, 2018.
- Conversion Price: $7.00 per share of Common Stock (subject to adjustments).
- Consideration Received: Warrants to purchase 33,333 shares of Common Stock (post-reverse stock split basis) held by Intracoastal Capital LLC.
- Ownership Limitation: Holder cannot convert if it would beneficially own more than 9.99% of outstanding Common Stock.
Material Changes and Transaction Mechanics
The Company entered into a Warrant Exchange Agreement with Intracoastal Capital LLC. The primary material change is the conversion of equity warrants into a debt instrument with equity conversion rights.
- Default Provisions: An "event of default" triggers a penalty interest rate of 18% and allows the holder to convert at a discounted price (70% of the lowest VWAP over the prior 10 trading days).
- Default Triggers: Include suspension of trading for 5 consecutive days, failure to deliver shares upon conversion, failure to pay amounts due, bankruptcy/insolvency, or uncured breaches of representations/warranties.
- Most Favored Nation Clause: If the Company offers more favorable terms to other holders of 2017 Warrants, Intracoastal is entitled to those terms unless they elect otherwise within 10 trading days.
Guidance, Risks, and Contingencies
Management Commentary: The agreement resulted from private negotiations between the Company and Intracoastal. No forward-looking guidance or outlook regarding future financial performance is provided in this filing.
Risks and Contingencies:
- Dilution Risk: Conversion of the note into common stock will result in dilution to existing shareholders.
- Default Risk: Failure to meet payment obligations or trading requirements could trigger a punitive interest rate and a significantly lower conversion price, increasing potential dilution.
- Liquidity: The note represents a direct financial obligation due in November 2018, impacting future cash flow requirements.
Investor Verification Checklist
- Verify the current trading status of the Common Stock to assess the risk of a trading suspension triggering default.
- Review the full text of the Warrant Exchange Agreement (Exhibit 10.1) for complete terms and conditions.
- Monitor the Company's cash position to ensure ability to repay the $78,000 principal plus accrued interest by November 25, 2018, if not converted.
- Check for any subsequent agreements with other 2017 Warrant holders that might trigger the "most favored nation" clause for Intracoastal.
- Confirm the current number of outstanding shares to calculate the potential dilution impact of the 9.99% ownership cap.